Weak electromagnetic fields potentiate the effects of 4-aminopyridine in multiple sclerosis.
Sandyk
R
R
D015761:4-Aminopyridine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004574:Electromagnetic Fields; D005260:Female; D006801:Humans; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000628:therapy*
D015761:4-Aminopyridine